OrthAlign manufactures KneeAlign, a computer-assisted navigation application for total knee replacement that has powered more than 65,000 surgeries and is supported by over 15 peer-reviewed studies. The company positions KneeAlign as a low-capital, sterile-field navigation alternative to large-console navigation and robotics, claiming reduced instrumentation and direct information delivery to surgeons. OrthAlign has expanded its commercial platform to include UniAlign for partial knee replacement and is developing HipAlign for total hip replacement; HipAlign was in limited user release with full commercialization slated for 2018. The company intends to transition from a single-solution provider to a platform technology provider serving total knee, partial knee, and total hip procedures. OrthAlign plans commercial expansion through hiring and programs in the U.S. and international markets. The business raised financing to support product development and continued commercial growth. OrthAlign, based in Aliso Viejo, CA, provides precision alignment technology and products for orthopedic surgeons. Its KneeAlign is a palm-sized, single-use device that provides both tibial and femoral navigation and is compatible with all implant systems. KneeAlign has been used in more than 21,000 cases worldwide. The company plans to launch OrthAlign Plus, a handheld navigation alternative for Total Hip Arthroplasty that allows surgeons to position the acetabular cup and measure leg length and offset; OrthAlign Plus is slated to be commercially available in early 2015. OrthAlign intends to use the $15M funding to launch the new hip product, increase sales and marketing activities, and continue international distributor expansion. The company is led by CEO William E. Maya. OrthAlign develops medical devices for computer-assisted surgery. The company is based in Laguna Beach. On February 8, 2010 it raised $5.16M in a Series A-2 funding round. The source of that funding was not announced by the firm. OrthAlign had previously raised capital from Okapi Venture Capital and Research Corporation Technologies. The new funding brings the company's total raised to just over $12.3M. OrthAlign is developing a line of computer-assisted surgical devices aimed at the total joint replacement market. The company is headquartered in Laguna Beach and is led by President and CEO Pieter Wolters. OrthAlign announced a $7.2M Series A financing to fund product development and commercialization. The round was led by Research Corporation Technologies and Okapi Venture Capital and included seed investors and other private backers. CEO Pieter Wolters and seed investors D. Ronald Yogada and Ned Scheetz were named as participants in the raise. Management said the proceeds will be used to finish developing the firm’s first products and bring them to market.

Total raised

$37M

Funding rounds

4

Latest round

Series D

Latest activity

Sep 2017